Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma
NCT ID: NCT00425061
Last Updated: 2015-01-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
159 participants
INTERVENTIONAL
2007-02-28
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating IMA-638 in Asthma
NCT00339872
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
NCT00603382
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392
Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma
NCT00870584
A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults
NCT00968669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
IMA-638
SC Injection, 12 weeks
2
IMA-638
SC Injection, 12 weeks
3
placebo
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IMA-638
SC Injection, 12 weeks
IMA-638
SC Injection, 12 weeks
placebo
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of treatment with a medium to high dose of inhaled corticosteroids (ICS), with or without long-acting beta-agonists (LABA), for at least 2 months prior to the screening visit and must remain constant during the study.
* FEV1 ≥ 55% to ≤ 80% predicted and demonstrated improvement in FEV1 (L) with inhaled albuterol (salbutamol) (reversibility) of ≥ 12%.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alabama Allergy and Asthma Center
Birmingham, Alabama, United States
Alabama Allergy & Asthma Clinic
Montgomery, Alabama, United States
Little Rock Allergy & Asthma
Little Rock, Arkansas, United States
Pacific Coast Allergy
Crescent City, California, United States
ABM Research Center
Fresno, California, United States
Allergy and Asthma Care Center of Southern California
Long Beach, California, United States
Allergy Medical Clinic
Los Angeles, California, United States
Advances in Medicine
Rancho Mirage, California, United States
Penisula Research Associates
Rolling Hills Estates, California, United States
Sharp Rees-Stealy Medical Group
San Diego, California, United States
Allergy Associates Medical Group, Inc.
San Diego, California, United States
Allergy & Asthma Assoc of Santa Clara Valley Research Ctr
San Jose, California, United States
San Jose Clinical Research, Inc.
San Jose, California, United States
Bensch Research Associates
Stockton, California, United States
Allergy and Immunology Medical Group
Vista, California, United States
Allergy & Asthma Clinical Research, Inc.
Walnut Creek, California, United States
National Jewish Medical & Research Center
Denver, Colorado, United States
Colorado Allergy and Asthma Centers
Denver, Colorado, United States
Waterbury Pulmonary Associates
Waterbury, Connecticut, United States
Brandon-Valico Center for Allergy & Asthma Research, LLC
Valrico, Florida, United States
Roberson Allergy & Asthma
West Palm Beach, Florida, United States
Georgia Pollens CRC, Inc.
Albany, Georgia, United States
DataQuest Medical Research
Lawrenceville, Georgia, United States
Aero Allergy Research Labs of Savannah, Inc. 505 Eisenhower
Savannah, Georgia, United States
Allergy and Asthma Center of Chicago
River Forest, Illinois, United States
Fort Wayne Medical Institute
Fort Wayne, Indiana, United States
South Bend Clinic
South Bend, Indiana, United States
College Park Family Care Center
Overland Park, Kansas, United States
Kansas City Allergy & Asthma
Overland Park, Kansas, United States
Abraham Research, PLLC
Crescent Springs, Kentucky, United States
Clinical Research Specialists
Metairie, Louisiana, United States
Allergy and Arthritis Family
Gardner, Massachusetts, United States
Center for Clinical Research
Taunton, Massachusetts, United States
Clinical Research Institute
Minneapolis, Minnesota, United States
Mississippi Asthma and Allergy Clinic, P.A.
Jackson, Mississippi, United States
Midwest Clinical Research LLC
St Louis, Missouri, United States
The Clinical Research Center LLC
St Louis, Missouri, United States
Montana Medical Research, Inc
Missoula, Montana, United States
Midwest Allergy and Asthma Clinic
Omaha, Nebraska, United States
Allergy and Asthma Assoc
Las Vegas, Nevada, United States
Princeton Center for Clinical Research
Skillman, New Jersey, United States
Pulmonary and Allergy Associates
Summit, New Jersey, United States
Pulmonary & Critical Care Services, P.C.5 Palisades Dr., Su
Albany, New York, United States
AAIR Research Center
Rochester, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Regional Allergy and Asthma Consultants, P.A.
Asheville, North Carolina, United States
AAC Research, PC
Mt Pleasant, North Carolina, United States
North Carolina Clinical Research
Raleigh, North Carolina, United States
Allergy & Respiratory Center
Canton, Ohio, United States
New Horizons Clinical Research
Cincinnati, Ohio, United States
Toledo Center for Clinial Researcch
Sylvania, Ohio, United States
Allergy, Asthma & Clinical Research Center
Oklahoma City, Oklahoma, United States
Allergy and Asthma Research Group
Eugene, Oregon, United States
Allergy, Asthma and Dermatology Research Center, LLC 3975 Me
Lake Oswego, Oregon, United States
Clinical Research Institute of Southern Oregon
Medford, Oregon, United States
Allergy Associates Research Center
Portland, Oregon, United States
Valley Clinical Research Center
Bethlehem, Pennsylvania, United States
Allergy & Asthma Research of New Jersey
Philadelphia, Pennsylvania, United States
Allergy and Clinical Immunology
Pittsburgh, Pennsylvania, United States
Pulmonary and Allergy Associates
Sellersville, Pennsylvania, United States
AAPRI Clinical Research Institute
Lincoln, Rhode Island, United States
Allergic Disease and Asthma Center Research, PA
Greenville, South Carolina, United States
AAC Research, PC
Mt. Pleasant, South Carolina, United States
East Tennessee Center for Clinical Research
Knoxville, Tennessee, United States
Lovelace Scientific Resources
Austin, Texas, United States
Allergy and Asthma Research Center of El Paso
El Paso, Texas, United States
Family Center for Asthma & Allergic Diseases
Friendswood, Texas, United States
Allergy and Asthma Associates
Houston, Texas, United States
Clinical Trials North Houston
Houston, Texas, United States
Clinical Trial Network
Houston, Texas, United States
The Allergy and Asthma Clinic of Central Texas
Killeen, Texas, United States
Allergy Asthma and Immunology
San Antonio, Texas, United States
Timber Lane Allergy and Asthma Research LLC
South Burlington, Vermont, United States
Virginia Adult & Pediatric Allergy & Asthma, P.C.
Richmond, Virginia, United States
University of Wisconsin Medical School
Madison, Wisconsin, United States
Auroroa Health Care, Inc.
Milwaukee, Wisconsin, United States
Alpha Medical Research Inc.
Mississauga, Ontario, Canada
Alexander Medical Innovations Inc.
Niagara Falls, Ontario, Canada
Allergy and Asthma Research Centre
Ottawa, Ontario, Canada
Recherche Invascor Inc
Longueuil, Quebec, Canada
Hopital du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
CIC Mauricie Inc.
Trois-Rivières, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2421007
Identifier Type: OTHER
Identifier Source: secondary_id
3174K1-201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.